Amanda Shrewsbury is the founder of ClearPath Genetics, a telehealth-first practice focused on hereditary cancer risk assessment and genetic testing. She previously provided bilingual genetic counseling at UCLA Health and worked in clinical program operations at Levels. She also serves as a program advisory board member and lecturer at Southern California University of Health Sciences.